thérapie (3) procès (3) cancer (3) Treatment (3) Cancer (3) Therapeutics (3) Cancer (3) Breast (3) surveillance (2) maladie (2) survie (2) Monitoring (2) Control (2) Methods (2) Survival (2) Patients (2) Molecules (2) Manufacturers' agents (2) Days (2) Commission merchants (2) Cancer--Patients (2) Doxorubicin (2) Bevacizumab (2) Methods (2) Patients (2) maladie (2) toxicité (1) temps (durée) (1) test (1) norme (1)